Efficacy and safety of trastuzumab emtansine treatment in patients with metastatic HER-2 positive breast cancer: a single center study

Introduction: Trastuzumab emtansine (T-DM1) is one of the effective treatment options in human epidermal growth factor receptor 2 (HER2) positive breast cancer patients. In this study, we aimed to find the effect of T-DM1 on survival, its tolerability and prognostic factors of T-DM1 treatment. Mater...

Description complète

Détails bibliographiques

Publié dans:	Iberoamerican Journal of Medicine
Auteurs principaux:	Eyyup Cavdar, Kubilay Karaboyun, Yakup Iriagac, Okan Avci, Erdoğan Selcuk Seber
Format:	Artigo
Langue:	Inglês
Publié:	Hospital San Pedro 2022
Sujets:	Medicina
Accès en ligne:	https://www.redalyc.org/articulo.oa?id=692072548004 https://www.redalyc.org/journal/6920/692072548004/ https://www.redalyc.org/journal/6920/692072548004/html/ https://www.redalyc.org/journal/6920/692072548004/692072548004.epub https://www.redalyc.org/journal/6920/692072548004/movil https://doi.org/10.53986/ibjm.2022.0033
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!